ISOSORBIDE-5-MONONITRATE — all Canadian products
10 DINs
5 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is ISOSORBIDE-5-MONONITRATE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02272830 | APO-ISMN | APOTEX INC | Tablet (Extended-Release) | Oral | ISOSORBIDE-5-MONONITRATE 60 MG | Marketed | |
| 02301288 | PMS-ISMN | PHARMASCIENCE INC | Tablet (Extended-Release) | Oral | ISOSORBIDE-5-MONONITRATE 60 MG | Marketed | |
| 02311321 | PRO-ISMN - 60 | PRO DOC LIMITEE | Tablet (Extended-Release) | Oral | ISOSORBIDE-5-MONONITRATE 60 MG | Marketed | |
| 02562561 | PRZ-ISMN | PHARMARIS CANADA INC | Tablet (Extended-Release) | Oral | ISOSORBIDE-5-MONONITRATE 60 MG | Marketed | |
| 02570742 | RIVA-ISMN | LABORATOIRE RIVA INC. | Tablet (Extended-Release) | Oral | ISOSORBIDE-5-MONONITRATE 60 MG | Approved | |
| 02307758 | DOM-ISMN | DOMINION PHARMACAL | Tablet (Extended-Release) | Oral | ISOSORBIDE-5-MONONITRATE 60 MG | Cancelled Pre Market | |
| 02126559 | IMDUR | JUNO PHARMACEUTICALS CORP. | Tablet (Extended-Release) | Oral | ISOSORBIDE-5-MONONITRATE 60 MG | Dormant | |
| 02446073 | ISMN | SIVEM PHARMACEUTICALS ULC | Tablet (Extended-Release) | Oral | ISOSORBIDE-5-MONONITRATE 60 MG | Cancelled Post Market | |
| 02058472 | ISMO TAB 20MG | WYETH-AYERST CANADA INC. | Tablet | Oral | ISOSORBIDE-5-MONONITRATE 20 MG | Cancelled Post Market | |
| 02307731 | PHL-ISMN | PHARMEL INC | Tablet (Extended-Release) | Oral | ISOSORBIDE-5-MONONITRATE 60 MG | Cancelled Pre Market |
Browse other molecules: